首页> 外国专利> Isolated nucleic acid molecule, fusion polypeptide, composition, vector, vector system, host vector system, methods of producing a fusion polypeptide.

Isolated nucleic acid molecule, fusion polypeptide, composition, vector, vector system, host vector system, methods of producing a fusion polypeptide.

机译:分离的核酸分子,融合多肽,组成,载体,载体系统,宿主载体系统,产生融合多肽的方法。

摘要

"ISOLATED NUCLEIC ACID MOLECULE, FUSION POLYPEPTIDE, COMPOSITION, VECTOR, VECTOR SYSTEM, HOST, METHOD OF PRODUCING A FUSION POLYPEPTIDE, AND USE OF A FUSION POLYPEPTIDE". Chimeric polypeptides modified with improved pharmacokinetics are disclosed. Specifically, modified chimeric Fltl receptor polypeptides that have been modified in such a way as to improve their pharmacokinetic profile are disclosed. Also disclosed are methods of making and using the modified polypeptides including but not limited to using the modified polypeptides to decrease or inhibit plasma leakage and / or vascular permeability in a mammal.
机译:“隔离的核酸分子,融合多肽,组合物,矢量,矢量系统,宿主,制备融合多肽的方法以及融合多肽的使用”。公开了用改善的药代动力学修饰的嵌合多肽。具体地,公开了已被修饰以改善其药代动力学特征的修饰的嵌合Flt1受体多肽。还公开了制备和使用修饰的多肽的方法,包括但不限于使用修饰的多肽减少或抑制哺乳动物的血浆渗漏和/或血管通透性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号